Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

PRCT PROCEPT BioRobotics Corporation Common Stock
$29.64 -2.91% -0.90
Notify me if price changes either direction
Interactive Brokers Logotype

Buy PRCT stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 1.7B
Enterprise value 1.5B
Trailing PE -16.934285714286
Forward PE -28.317078
PEG Ratio 3.3868571428571
Enterprise to EBITDA -17.525
Enterprise to revenue 5.049
Price to book MRQ 4.547458
Price to sales TTM 5.7665954

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 299.9M
EBITDA -86394000
Diluted EPS TTM -1.53
Total Cash (MRQ) 294.3M
Current ratio (MRQ) 8.437
Operating Cash Flow (TTM) -71049000

PRCT trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent PRCT News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.